Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events

Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events

Show other versions (1)

Aim. Pharmacoeconomic analysis of apixaban use compared to conventional therapy in patients with venous thromboembolism (VTE).Material and methods. Economic evaluation was performed from a position of the health care system. The cost analysis, "cost-effectiveness" analysis, "impact on...

Full description

Bibliographic Details
Main Author: O. V. Shatalova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
pharmacoeconomics
new oral anticoagulants
apixaban
venous thromboembolism
Online Access:https://www.rpcardio.com/jour/article/view/439

Similar Items

Similar Items